Revolution Medicines, Inc. Public Float
Revolution Medicines, Inc. (RVMD) had Public Float of $6.70 billion as of 2025-06-30, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-25
- 2025-06-30: Entity Public Float $6.70B.
- 2024-06-30: Entity Public Float $6.50B.
- 2023-06-30: Entity Public Float $2.76B.
- 2022-06-30: Entity Public Float $1.23B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $6.70B 10-K · filed 2026-02-25 |
| 2024-06-30 | $6.50B 10-K · filed 2025-02-26 |
| 2023-06-30 | $2.76B 10-K · filed 2024-02-26 |
| 2022-06-30 | $1.23B 10-K · filed 2023-02-27 |
| 2021-06-30 | $1.96B 10-K · filed 2022-02-28 |
| 2020-06-30 | $1.11B 10-K · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |